US equities
|
NVDA
$221.30
▼-3.16%
MU
$914.13
▼-4.10%
AAPL
$342.96
▲+0.50%
AMD
$570.82
▼-5.73%
META
$737.54
▼-3.27%
MSFT
$533.69
▼-1.80%
TSLA
$367.16
▼-2.15%
SPCX
$152.16
▼-2.80%
NVDA
$221.30
▼-3.16%
MU
$914.13
▼-4.10%
AAPL
$342.96
▲+0.50%
AMD
$570.82
▼-5.73%
META
$737.54
▼-3.27%
MSFT
$533.69
▼-1.80%
TSLA
$367.16
▼-2.15%
SPCX
$152.16
▼-2.80%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about NASDAQ:APLS
Recent news which mentions NASDAQ:APLS
APLS Stock Earnings: Apellis Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024
May 07, 2024
Tickers
APLS
Tags
NASDAQ:APLS
APLS
Earnings Reports
From
InvestorPlace
Apellis Pharmaceuticals stock has lost 40% in 2024: buy the dip?
April 30, 2024
Tickers
APLS
USA
Tags
NASDAQ:APLS
North America
Health & pharma
From
Invezz
Better Pharmaceutical Stock: Apellis or Novartis?
September 14, 2021
Tags
NYSE:NVS
NASDAQ:APLS
From
StockNews.com
APLS Stock: The Trial Results That Have Apellis Pharmaceuticals Plunging Today
September 10, 2021
Tickers
APLS
Tags
NASDAQ:APLS
APLS
Market News
From
InvestorPlace